Structure-based drug design relies on static protein structures despite significant evidence for the need to include protein dynamics as a serious consideration. In practice, dynamic motions are neglected because they are not understood well enough to model – a situation resulting from a lack of explicit experimental examples of dynamic receptor-ligand complexes. Here, we report high-resolution details of pronounced ~1 ms timescale motions of a receptor-small molecule complex using a combination of NMR and X-ray crystallography. Large conformational dynamics in Escherichia coli dihydrofolate reductase are driven by internal switching motions of the drug-like, nanomolar-affinity inhibitor. Carr-Purcell-Meiboom-Gill relaxation dispersion expe...
G protein-coupled receptors (GPCRs) are implicated in nearly every physiological process in the huma...
These authors contributed equally. Protein-protein association is often accompanied by changes in re...
The key objectives of computational structure-based drug design include the prediction of the protei...
Structure-based drug design relies on static protein structures despite significant evidence for the...
High-resolution protein crystal structures have served as the template from which to devise small mo...
The intrinsic dynamics of macromolecules is an essential property to relate the structure of biomole...
Signal transduction, regulatory processes, and pharmaceutical responses are highly dependent upon li...
The arduous task of rationally designing small molecule enzyme inhibitors is complicated by the inhe...
The proper understanding of biomolecular recognition mechanisms that take place in a drug target is ...
Proteins are not static objects. To carry out their functions in the cells and participate in bioch...
AbstractProtein-protein association is often accompanied by changes in receptor and ligand structure...
SummaryThe arduous task of rationally designing small-molecule enzyme inhibitors is complicated by t...
The recent paradigm shift toward the use of the kinetics parameters in place of thermodynamic consta...
Understanding the dynamics of ligands bound to proteins is an important task in medicinal chemistry ...
Protein-protein association is often accompanied by changes in receptor and ligand structure. This i...
G protein-coupled receptors (GPCRs) are implicated in nearly every physiological process in the huma...
These authors contributed equally. Protein-protein association is often accompanied by changes in re...
The key objectives of computational structure-based drug design include the prediction of the protei...
Structure-based drug design relies on static protein structures despite significant evidence for the...
High-resolution protein crystal structures have served as the template from which to devise small mo...
The intrinsic dynamics of macromolecules is an essential property to relate the structure of biomole...
Signal transduction, regulatory processes, and pharmaceutical responses are highly dependent upon li...
The arduous task of rationally designing small molecule enzyme inhibitors is complicated by the inhe...
The proper understanding of biomolecular recognition mechanisms that take place in a drug target is ...
Proteins are not static objects. To carry out their functions in the cells and participate in bioch...
AbstractProtein-protein association is often accompanied by changes in receptor and ligand structure...
SummaryThe arduous task of rationally designing small-molecule enzyme inhibitors is complicated by t...
The recent paradigm shift toward the use of the kinetics parameters in place of thermodynamic consta...
Understanding the dynamics of ligands bound to proteins is an important task in medicinal chemistry ...
Protein-protein association is often accompanied by changes in receptor and ligand structure. This i...
G protein-coupled receptors (GPCRs) are implicated in nearly every physiological process in the huma...
These authors contributed equally. Protein-protein association is often accompanied by changes in re...
The key objectives of computational structure-based drug design include the prediction of the protei...